FOIA Number: SEC-21-0930

News Roundup: Presidential Coups and Election Reviews

December 17, 2021
New and alarming details about the involvement of key figures — from members of Congress to Kanye West — in former President Donald Trump’s bid to overturn a free and fair election have continued to trickle out over the last week.

GLOMAR from SEC Regarding Investigations into Emergent Bio Solutions CEO’s Stock Sales

July 29, 2021
The U.S. Securities and Exchange Commission stated that it could not confirm or deny the existence of records responsive to American Oversight's request for documents relevant to any agency investigations into Emergent BioSolutions CEO Robert Kramer’s sale of his company’s stock shortly before its stock prices plummeted because of the contamination of Johnson & Johnson Covid-19 vaccines.

FOIA to SEC for Records Regarding Investigations into Emergent BioSolutions CEO’s Stock Sales

July 15, 2021
FOIA request to the U.S. Securities and Exchange Commission for documents relevant to any agency investigations into Emergent BioSolutions CEO Robert Kramer's sale of his company's stock shortly before its stock prices plummeted because of the contamination of Johnson & Johnson Covid-19 vaccines.